Skip to content

Investigators’ meeting

On 4th and 5th June 2019, the First Pyrapreg Investigators’ Meeting took place at the Medical Research Council Unit, in The Gambia. The meeting was chaired by Prof. Umberto D’Alessandro, the leader of WP2. Seven of the eight countries involved in the Pyrapreg Consortium were represented: Mali, Burkina Faso, Democratic Republic of the Congo, The Gambia, United Kingdom, Mozambique, and The Netherlands.

The objectives of the first investigators’ meeting were:

  • To discuss the protocol and decide on a few issues (pharmacokinetics aspects, data management, monitoring, composition of the Data Safety and Monitoring Board, etc)
  • To elaborate the projects timelines (finalize the study protocol and the source document, ethical clearance,

The fruitful discussions allowed reaching compromise on all key issues indicated in the meeting objectives. It was also the opportunity for several Consortium members to meet physically for the first time.